Forma Therapeutics Statistics Share Statistics Forma Therapeutics has 0
shares outstanding. The number of shares has increased by 0.96%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0.96% Shares Change (QoQ) 5.65% Owned by Institutions (%) n/a Shares Floating 33.11M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 674.07K, so 0% of the outstanding
shares have been sold short.
Short Interest 674.07K Short % of Shares Out n/a Short % of Float 1.61% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -3.38 and the forward
PE ratio is null.
Forma Therapeutics's PEG ratio is
-0.09.
PE Ratio -3.38 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.17 P/FCF Ratio -3.79 PEG Ratio -0.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Forma Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.86,
with a Debt / Equity ratio of 0.07.
Current Ratio 13.86 Quick Ratio 13.86 Debt / Equity 0.07 Debt / EBITDA -0.19 Debt / FCF -0.21 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-915.15K Employee Count 189 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 154K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.95, so Forma Therapeutics's
price volatility has been lower than the market average.
Beta -0.95 52-Week Price Change n/a 50-Day Moving Average 16.65 200-Day Moving Average n/a Relative Strength Index (RSI) 86.85 Average Volume (20 Days) 1,553,402
Income Statement
Revenue n/a Gross Profit n/a Operating Income -172.81M Net Income -172.96M EBITDA -171.24M EBIT -172.81M Earnings Per Share (EPS) -4.21
Full Income Statement Balance Sheet The company has 77.42M in cash and 32.74M in
debt, giving a net cash position of 44.68M.
Cash & Cash Equivalents 77.42M Total Debt 32.74M Net Cash 44.68M Retained Earnings -230.37M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -149.79M
and capital expenditures -4.18M, giving a free cash flow of -153.97M.
Operating Cash Flow -149.79M Capital Expenditures -4.18M Free Cash Flow -153.97M FCF Per Share -3.75
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
